1. Home
  2. CVKD vs JTAI Comparison

CVKD vs JTAI Comparison

Compare CVKD & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • JTAI
  • Stock Information
  • Founded
  • CVKD 2022
  • JTAI 2018
  • Country
  • CVKD United States
  • JTAI United States
  • Employees
  • CVKD N/A
  • JTAI N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • JTAI Blank Checks
  • Sector
  • CVKD Health Care
  • JTAI Finance
  • Exchange
  • CVKD Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • CVKD 29.5M
  • JTAI 9.9M
  • IPO Year
  • CVKD 2023
  • JTAI N/A
  • Fundamental
  • Price
  • CVKD $11.47
  • JTAI $3.60
  • Analyst Decision
  • CVKD Strong Buy
  • JTAI
  • Analyst Count
  • CVKD 1
  • JTAI 0
  • Target Price
  • CVKD $32.00
  • JTAI N/A
  • AVG Volume (30 Days)
  • CVKD 33.0K
  • JTAI 329.3K
  • Earning Date
  • CVKD 08-06-2025
  • JTAI 08-13-2025
  • Dividend Yield
  • CVKD N/A
  • JTAI N/A
  • EPS Growth
  • CVKD N/A
  • JTAI N/A
  • EPS
  • CVKD N/A
  • JTAI N/A
  • Revenue
  • CVKD N/A
  • JTAI $13,648,668.00
  • Revenue This Year
  • CVKD N/A
  • JTAI $13.37
  • Revenue Next Year
  • CVKD N/A
  • JTAI $201.13
  • P/E Ratio
  • CVKD N/A
  • JTAI N/A
  • Revenue Growth
  • CVKD N/A
  • JTAI N/A
  • 52 Week Low
  • CVKD $5.70
  • JTAI $2.30
  • 52 Week High
  • CVKD $22.90
  • JTAI $97.40
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 40.38
  • JTAI 42.57
  • Support Level
  • CVKD $10.02
  • JTAI $3.41
  • Resistance Level
  • CVKD $13.71
  • JTAI $3.95
  • Average True Range (ATR)
  • CVKD 1.08
  • JTAI 0.25
  • MACD
  • CVKD -0.13
  • JTAI 0.00
  • Stochastic Oscillator
  • CVKD 29.72
  • JTAI 22.54

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: